Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab

scientific article published on August 2010

Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/RHU.0B013E3181E931FA
P698PubMed publication ID20577094

P2093author name stringRodney Tehrani
Eugene A Bacorro
P433issue5
P921main subjectantibodyQ79460
stiff-person syndromeQ1235785
P304page(s)237-239
P577publication date2010-08-01
P1433published inJournal of Clinical RheumatologyQ15766312
P1476titleStiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab
P478volume16

Reverse relations

cites work (P2860)
Q36484465Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
Q28264405Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes
Q30518011Childhood stiff-person syndrome improved with rituximab.
Q95840283GAD antibodies in neurological disorders - insights and challenges
Q51210635GAD65 neurological autoimmunity.
Q86705300Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies
Q37968620Monoclonal antibodies and recombinant immunoglobulins for the treatment of multiple sclerosis.
Q92860583Quantification of aminobutyric acids and their clinical applications as biomarkers for osteoporosis
Q28295552The immunological basis for treatment of stiff person syndrome